Lei Zeng
No. 1 Minde Road
Nanchang, 330006, China
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Overlap-adapted Subvolume Prescription to Reduce Temporal Lobe Injury Risk in T4 Nasopharyngeal Carcinoma: A Prospective Cohort Study with a Contemporaneous Comparator.
Journal: Practical radiation oncology
Published: April 27, 2026
Causal Machine Learning Analysis of Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis in Head and Neck Cancer Radiotherapy.
Journal: ArXiv
Published: October 03, 2025
Erratum for: Normal Tissue Complication Probability Model for Radiation-induced Temporal Lobe Injury after Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Journal: Radiology
Published: September 30, 2025
Causal Machine Learning Analysis of Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis in Head and Neck Cancer Radiotherapy.
Journal: International journal of radiation oncology, biology, physics
Published: September 25, 2025
Correction: Pre-treatment serum apolipoprotein E: a promising prognostic indicator for nasopharyngeal carcinoma.
Journal: European journal of medical research
Published: August 22, 2025
Targeting SHP2 to reverse immune evasion and resistance to anti-PD-1 therapy in non-small cell lung cancer.
Journal: Cell communication and signaling : CCS
Published: July 14, 2025
Prognostic value of serum uric acid levels following radiotherapy and chemotherapy in nasopharyngeal carcinoma.
Journal: Molecular and clinical oncology
Published: July 09, 2025
Defining ARID1A-Driven WEE1 Vulnerability and Clarifying Its Predictive Value in EGFR-Mutant NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 16, 2025
ETV5 transcriptionally activates LGR4 and promotes cancer cell invasion and migration of nasopharyngeal carcinoma.
Journal: Journal of molecular histology
Published: May 27, 2025
FHL2 facilitates LUSC growth and therapy resistance through PI3K/AKT/mTOR activation.
Journal: The Journal of biological chemistry
Published: March 19, 2025
Last Updated: 09/26/2026